Thailand Diabetes Care Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 128.94 Million |
| Market Size (2029) | USD 175.49 Million |
| CAGR (2024 - 2029) | 6.36 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Thailand Diabetes Care Devices Market Analysis
The Thailand Diabetes Care Devices Market size is estimated at USD 128.94 million in 2024, and is expected to reach USD 175.49 million by 2029, growing at a CAGR of 6.36% during the forecast period (2024-2029).
Thailand possesses the seventh highest number of individuals with diabetes in the Western Pacific region, accounting for 9.9% of the adult population. Diabetes stands as a prominent contributor to mortality rates in Thailand. Out of the 200,000 deaths caused by chronic non-communicable diseases each year, around 30,000 (15%) can be attributed to diabetes.
Diabetes mellitus is a medical condition characterized by elevated blood sugar levels caused by insufficient insulin production, impaired insulin secretion, or a combination of both. Prolonged hyperglycemia can lead to damage, deterioration, and malfunction of essential organs. The inability to manage blood sugar levels can be attributed to factors that cannot be changed, such as gender, age, duration of diabetes, and complications related to blood vessels and other organs.
On the other hand, factors that can be modified include behavioral and psychosocial aspects, like unhealthy eating habits, lack of physical activity, obesity, failure to follow medical advice, and neglecting prescribed medication. Additionally, stress, depression, and anxiety, particularly those related to diabetes, can also contribute to difficulties in controlling blood sugar levels.
Disposable prefilled insulin pens, both long-acting and short-acting analogs, were chosen instead of insulin vials to reduce administration errors, particularly in insulin-naïve patients. Insulin pens were kept at a medical clinic and distributed in a temperature-controlled container by a same-day delivery service.
Thus increasing diabetes population is driving the diabetes care devices market in projected timeframe.
Thailand Diabetes Care Devices Market Trends
Management Devices Segment is Having Highest Share in current year
Blood pressure regulation is a critical component of diabetes management. Furthermore, even without high blood pressure, certain blood pressure-lowering medications are frequently recommended for people with diabetes to protect them from kidney and heart-related complications. No scientific evidence links these blood pressure drugs to the likelihood of COVID-19 infection or associated consequences. High blood sugar levels (hyperglycemia) are a symptom of diabetes mellitus, which a lack of insulin hormones can bring on, a problem with insulin secretion, or both.
High blood sugar levels can cause essential organs to malfunction, deteriorate, and be destroyed. Both changeable and immutable variables can contribute to an inability to control blood sugar levels. Gender, age, the length of diabetes, microvascular and macrovascular complications, and comorbidities are non-modifiable factors. Behavioral and psychosocial problems, such as poor eating habits, inactivity, obesity, and failure to take prescribed medications as directed by a doctor, as well as stress, sadness, and anxiety, particularly anxiety associated with diabetes, are examples of modifiable factors.
Insulin therapy is the most potent hypoglycaemic medication currently available for diabetes treatment; however, the potency of insulin deteriorates if it is stored under improper conditions. In Thailand, NCDs, including diabetes, account for more than 70% of all deaths. Obesity leads to a more than seven times increase in the risk of developing Type 2 diabetes while being overweight increases the risk by three times.
Through Thailand's government encouragement, the usage of Management Devices increased over the forecast period.
Increasing Diabetes population in Thailand is Driving the Market
The World Health Organization (WHO) estimates that in 2022, around 11% of the total health expenditure in Thailand will be allocated to diabetes care, which is comparable to other countries in the region. By 2030, this figure is expected to grow by 41%, effectively doubling the societal burden of diabetes. In Thailand, only 272 endocrinologists (or specialists) are available. In Thailand, three out of five people with diabetes who receive care do not achieve the recommended treatment targets.
According to the WHO's report, the world's top five countries suffering from diabetes include Indonesia, China, India, Brazil, and the United States. Thailand is facing an increase in the number of diabetes patients due to changing lifestyles, resulting in the prevalence of obesity. Sedentary lifestyles and unhealthy diets are more common in urban areas of Thailand.
The Thai government is attempting to address the threat of diabetes mellitus through programs like 'Thailand Healthy Lifestyle Strategic Plan 2011-2020'. Such programs will help diabetic patients understand the benefits of various diabetes devices available in the market. Diabetes is one of the biggest health issues facing the world today, and its prevalence is steadily rising.
According to the World Diabetes Federation, 450 million people worldwide already have diabetes, and 642 million will have it by 2041. Asian nations account for more than 60% of those with diabetes worldwide2. Furthermore, compared to people of other races, Asians may be more prone to having type 2 diabetes and at a higher risk of getting diabetes complications.
The increasing diabetes population and the technological advancements in Indonesia drive the market.
Thailand Diabetes Care Devices Industry Overview
The new technologies in diabetes devices, like continuous glucose monitoring, increased the market for monitoring devices. The mergers and acquisitions between the players, like the acquisition of TypeZero Technologies by Dexcom, are paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead in the race to create an artificial pancreas system rather than merely offering a boost to the continuous glucose monitoring devices market.
Thailand Diabetes Care Devices Market Leaders
-
Medtronic
-
F. Hoffmann-La Roche AG
-
Novo Nordisk
-
Abbott Diabetes Care
-
Dexcom
*Disclaimer: Major Players sorted in no particular order
Thailand Diabetes Care Devices Market News
- October 2023: Phillips-Medisize and GlucoModicum collaborated on the creation of a novel CGM device known as the Talisman. This innovative device integrates magnetohydrodynamic technology, advanced algorithms, and biosensors. Additionally, it is designed to connect to a smartphone application for efficient data collection.
- April 2022: the Insulin Pen has been approved by the Thailand Food and Drug Administration (TFDA) through the cooperation between Gan & Lee Thai partner and Gan & Lee. The approved Insulin Pen can be used with the Gan & Lee 3mL cartridge insulin penfill. By adjusting the dose knob, patients are allowed to set 1-60 units (U) of insulin for administration. The minimum scale of the pen is accurate to 1 unit (U), which can meet the needs of diabetic patients for daily injections.
Thailand Diabetes Care Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
-
4.4 Industry Attractiveness - Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Monitoring Devices
- 5.1.1 Self-monitoring Blood Glucose Devices
- 5.1.1.1 Glucometer Devices
- 5.1.1.2 Test Strips
- 5.1.1.3 Lancets
- 5.1.2 Continuous Blood Glucose Monitoring
- 5.1.2.1 Sensors
- 5.1.2.2 Durables
-
5.2 Management Devices
- 5.2.1 Insulin Pump
- 5.2.1.1 Insulin Pump Device
- 5.2.1.2 Insulin Pump Reservoir
- 5.2.1.3 Infusion Set
- 5.2.2 Insulin Syringes
- 5.2.3 Insulin Cartridges
- 5.2.4 Disposable Pens
6. MARKET INDICATORS
- 6.1 Type-1 Diabetes population
- 6.2 Type-2 Diabetes population
7. COMPETITIVE LANDSCAPE
-
7.1 Company Profiles
- 7.1.1 Becton and Dickenson
- 7.1.2 Medtronic
- 7.1.3 Insulet
- 7.1.4 Tandem
- 7.1.5 Ypsomed
- 7.1.6 Novo Nordisk
- 7.1.7 Sanofi
- 7.1.8 Eli Lilly
- 7.1.9 Abbottt
- 7.1.10 Roche
- 7.1.11 Lifescan (Johnson &Johnson)
- 7.1.12 Dexcom
- *List Not Exhaustive
- 7.2 Company Share Analysis
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityThailand Diabetes Care Devices Industry Segmentation
The tools used in diabetes care are used to measure the body's blood sugar levels resulting from insulin synthesis. Patients with diabetes are given these care tools to monitor their blood glucose levels and better manage their chronic illnesses. Thailand Diabetes Care Devices Market is segmented into devices and Monitoring Devices. The report offers the value (in USD) and volume (in Units) for the above segments.
| Monitoring Devices | Self-monitoring Blood Glucose Devices | Glucometer Devices |
| Test Strips | ||
| Lancets | ||
| Monitoring Devices | Continuous Blood Glucose Monitoring | Sensors |
| Durables | ||
| Management Devices | Insulin Pump | Insulin Pump Device |
| Insulin Pump Reservoir | ||
| Infusion Set | ||
| Management Devices | Insulin Syringes | |
| Insulin Cartridges | ||
| Disposable Pens |
Thailand Diabetes Care Devices Market Research FAQs
How big is the Thailand Diabetes Care Devices Market?
The Thailand Diabetes Care Devices Market size is expected to reach USD 128.94 million in 2024 and grow at a CAGR of 6.36% to reach USD 175.49 million by 2029.
What is the current Thailand Diabetes Care Devices Market size?
In 2024, the Thailand Diabetes Care Devices Market size is expected to reach USD 128.94 million.
Who are the key players in Thailand Diabetes Care Devices Market?
Medtronic, F. Hoffmann-La Roche AG, Novo Nordisk, Abbott Diabetes Care and Dexcom are the major companies operating in the Thailand Diabetes Care Devices Market.
What years does this Thailand Diabetes Care Devices Market cover, and what was the market size in 2023?
In 2023, the Thailand Diabetes Care Devices Market size was estimated at USD 120.74 million. The report covers the Thailand Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thailand Diabetes Care Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Thailand Diabetes Care Devices Industry Report
Statistics for the 2024 Thailand Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Thailand Diabetes Care Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
